ALCAM (CD166) expression and serum levels are markers for...

International Journal of Cancer 2012 Vol. 131; Iss. 2

ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients

Michael Tachezy, Katharina Effenberger, Hilke Zander, Sarah Minner, Florian Gebauer, Yogesh K. Vashist, Guido Sauter, Klaus Pantel, Jakob R. Izbicki, Maximilian Bockhorn
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
131
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/ijc.26377
File:
PDF, 449 KB
english, 2012
Conversion to is in progress
Conversion to is failed